Smith & Nephew plc (SNN)
34.31
-0.54
(-1.55%)
USD |
NYSE |
Mar 06, 16:00
34.29
-0.02
(-0.06%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 14.66B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 19.12% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 2.528 |
| Price to Book Value | 3.622 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.482 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 55.07% |
Profile
| Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. |
| URL | http://www.smith-nephew.com |
| Investor Relations URL | N/A |
| HQ State/Province | Herefordshire |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 04, 2026 (est.) |
| Last Earnings Release | Mar. 02, 2026 |
| Next Ex-Dividend Date | Mar. 27, 2026 |
| Last Ex-Dividend Date | Oct. 03, 2025 |
Profile
| Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. |
| URL | http://www.smith-nephew.com |
| Investor Relations URL | N/A |
| HQ State/Province | Herefordshire |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 04, 2026 (est.) |
| Last Earnings Release | Mar. 02, 2026 |
| Next Ex-Dividend Date | Mar. 27, 2026 |
| Last Ex-Dividend Date | Oct. 03, 2025 |